06.09.2011

NNE Pharmaplan Extends International Business with A New Structure

Leading The Way - With sales of around €200 million in 2010, NNE Pharmaplan is one of the world's leading engineering and consulting companies for the pharmaceutical and biotechnology industries. Last year the group, whose headquarters are in Copenhagen, changed its organizational structure in order to improve its service to international customers and more consistently exploit opportunities for growth.

The subsidiaries in Germany, Switzerland and France are part of the Central Europe Region. The German headquarters is in Bad Homburg, near Frankfurt. Dr. more10.12.2010

Khaled Al-Mana On Sabic’s Culture of Innovation

Düsseldorf was buzzing at the end of October with hundreds of thousands of people from all over the world who came to Germany for the world's largest trade show for plastics and rubber, the K 2010. The show's organizers reported an excellent mood among the over 3,000 visitors, and the show itself exceeded industry expectations. more14.07.2010

Never Waste a Crisis

Resilience - The 16 months Lyondellbasell spent in Chapter11 was a time of belt tightening and strategic rethinking. Having emerged from bankruptcy in April with a net debt load reduced from over $24 billion to approximately $5 billion and a new top holding company - Lyondellbasell Industries NV - the company is planning a public listing on the New York Stock Exchange in Q3 of this year. more27.01.2010

Finding The Balance

The Exclusive Synthesis & Amino Acids Business Line within Evonik's Health & Nutrition Business Unit supplies the pharmaceutical and other industries with high-quality fine chemicals. In line with the concept of horizontal integration, customers get an optimal combination in terms of a good cost structure for intermediates and basic active ingredients from the production plants in Asia and for intermediates and active ingredients of higher complexity from sites in Europe and the U.S. Beginning this year Evonik acquired a U.S. more